ACCORD (2008) — Trial Summary

ACCORD (2008): Randomized trial in adults with type 2 diabetes at high cardiovascular risk comparing intensive glucose control (target HbA1c <6%) versus standard glucose control (target HbA1c 7.0–7.9%), with additional blood-pressure and lipid factorial arms (NCT00000620). Primary outcome: nonfatal

References

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.